These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23173138)

  • 1. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature.
    Schillie SF; Spradling PR; Murphy TV
    Diabetes Care; 2012 Dec; 35(12):2690-7. PubMed ID: 23173138
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients.
    Fabrizi F; Dixit V; Martin P; Messa P
    Aliment Pharmacol Ther; 2011 Apr; 33(7):815-21. PubMed ID: 21281319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
    Fabrizi F; Dixit V; Messa P; Martin P
    Aliment Pharmacol Ther; 2010 Sep; 32(6):756-62. PubMed ID: 20662784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid.
    Ocak S; Eskiocak AF
    Nephrology (Carlton); 2008 Dec; 13(6):487-91. PubMed ID: 18331434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine nonresponders: Possible mechanisms and solutions.
    Saco TV; Strauss AT; Ledford DK
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):320-327. PubMed ID: 29567355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccine recombinant (Janssen/Medeva). Hepagene.
    Drugs R D; 1999 Sep; 2(3):201-2. PubMed ID: 10641227
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.
    Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1053-62. PubMed ID: 15569107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccine recombinant (bio-technology general). BioHepB, Sci-B-Vac.
    Drugs R D; 1999 Sep; 2(3):199-200. PubMed ID: 10641226
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
    Jackson S; Lentino J; Kopp J; Murray L; Ellison W; Rhee M; Shockey G; Akella L; Erby K; Heyward WL; Janssen RS;
    Vaccine; 2018 Jan; 36(5):668-674. PubMed ID: 29289383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis.
    Wu Z; Bao H; Yao J; Chen Y; Lu S; Li J; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Xie TS; Hu Y
    Hum Vaccin Immunother; 2019; 15(1):220-227. PubMed ID: 30089437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus vaccine in chronic kidney diseases: improved immunogenicity by adjuvants? Limits of a meta-analysis.
    Di Pasquale A; De Ridder M; Van Der Meeren O
    Vaccine; 2012 Aug; 30(38):5586. PubMed ID: 22749597
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70 years.
    Hyer RN; Janssen RS
    Vaccine; 2019 Sep; 37(39):5854-5861. PubMed ID: 31431412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
    Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
    Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus as a vaccine-effect modifier: a review.
    Verstraeten T; Fletcher MA; Suaya JA; Jackson S; Hall-Murray CK; Scott DA; Schmöle-Thoma B; Isturiz RE; Gessner BD
    Expert Rev Vaccines; 2020 May; 19(5):445-453. PubMed ID: 32516066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
    Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination.
    Huang J; Ou HY; Lin J; Karnchanasorn R; Feng W; Samoa R; Chuang LM; Chiu KC
    PLoS One; 2015; 10(10):e0139730. PubMed ID: 26509504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of antibodies, but not of protection.
    Wenzel JJ; Jilg W
    Lancet Infect Dis; 2010 Nov; 10(11):738-9. PubMed ID: 21029981
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B vaccination for patients with chronic renal failure.
    Schroth RJ; Hitchon CA; Uhanova J; Noreddin A; Taback SP; Moffatt ME; Zacharias JM
    Cochrane Database Syst Rev; 2004; 2004(3):CD003775. PubMed ID: 15266500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.